Author:
Singhal Vibha,Misra Madhusmita
Publisher
Springer International Publishing
Reference75 articles.
1. Martinelli CE, Keogh JM, Greenfield JR, Henning E, van der Klaauw AA, Blackwood A, et al. Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion. J Clin Endocrinol Metab. 2011;96(1):E181–8.
2. de Waal WJ, Greyn-Fokker MH, Stijnen T, van Gurp EA, Toolens AM, de Munick Keizer-Schrama SM, et al. Accuracy of final height prediction and effect of growth-reductive therapy in 362 constitutionally tall children. J Clin Endocrinol Metab. 1996;81(3):1206–16.
3. Upners EN, Juul A. Evaluation and phenotypic characteristics of 293 Danish girls with tall stature: effects of oral administration of natural 17beta-estradiol. Pediatr Res. 2016;80(5):693–701.
4. Venn A, Bruinsma F, Werther G, Pyett P, Baird D, Jones P, et al. Oestrogen treatment to reduce the adult height of tall girls: long-term effects on fertility. Lancet. 2004;364(9444):1513–8.
5. Hendriks AE, Laven JS, Valkenburg O, Fong SL, Fauser BC, de Ridder MA, et al. Fertility and ovarian function in high-dose estrogen-treated tall women. J Clin Endocrinol Metab. 2011;96(4):1098–105.